EP3534775B1 - Device for physiological parameter detection - Google Patents
Device for physiological parameter detection Download PDFInfo
- Publication number
- EP3534775B1 EP3534775B1 EP17800470.1A EP17800470A EP3534775B1 EP 3534775 B1 EP3534775 B1 EP 3534775B1 EP 17800470 A EP17800470 A EP 17800470A EP 3534775 B1 EP3534775 B1 EP 3534775B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- light
- wavelength
- doped
- wavelength converter
- light source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02416—Measuring pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
- A61B5/02427—Details of sensor
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V40/00—Recognition of biometric, human-related or animal-related patterns in image or video data
- G06V40/10—Human or animal bodies, e.g. vehicle occupants or pedestrians; Body parts, e.g. hands
- G06V40/12—Fingerprints or palmprints
- G06V40/13—Sensors therefor
- G06V40/1318—Sensors therefor using electro-optical elements or layers, e.g. electroluminescent sensing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6825—Hand
- A61B5/6826—Finger
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10F—INORGANIC SEMICONDUCTOR DEVICES SENSITIVE TO INFRARED RADIATION, LIGHT, ELECTROMAGNETIC RADIATION OF SHORTER WAVELENGTH OR CORPUSCULAR RADIATION
- H10F55/00—Radiation-sensitive semiconductor devices covered by groups H10F10/00, H10F19/00 or H10F30/00 being structurally associated with electric light sources and electrically or optically coupled thereto
- H10F55/20—Radiation-sensitive semiconductor devices covered by groups H10F10/00, H10F19/00 or H10F30/00 being structurally associated with electric light sources and electrically or optically coupled thereto wherein the electric light source controls the radiation-sensitive semiconductor devices, e.g. optocouplers
- H10F55/25—Radiation-sensitive semiconductor devices covered by groups H10F10/00, H10F19/00 or H10F30/00 being structurally associated with electric light sources and electrically or optically coupled thereto wherein the electric light source controls the radiation-sensitive semiconductor devices, e.g. optocouplers wherein the radiation-sensitive devices and the electric light source are all semiconductor devices
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10F—INORGANIC SEMICONDUCTOR DEVICES SENSITIVE TO INFRARED RADIATION, LIGHT, ELECTROMAGNETIC RADIATION OF SHORTER WAVELENGTH OR CORPUSCULAR RADIATION
- H10F77/00—Constructional details of devices covered by this subclass
- H10F77/40—Optical elements or arrangements
- H10F77/496—Luminescent members, e.g. fluorescent sheets
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10H—INORGANIC LIGHT-EMITTING SEMICONDUCTOR DEVICES HAVING POTENTIAL BARRIERS
- H10H20/00—Individual inorganic light-emitting semiconductor devices having potential barriers, e.g. light-emitting diodes [LED]
- H10H20/80—Constructional details
- H10H20/85—Packages
- H10H20/851—Wavelength conversion means
- H10H20/8511—Wavelength conversion means characterised by their material, e.g. binder
- H10H20/8512—Wavelength conversion materials
- H10H20/8513—Wavelength conversion materials having two or more wavelength conversion materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
Definitions
- the present invention relates to a device for detecting light allowing retrieval of a physiological parameter of a user carrying said device.
- PPG photoplethysmography
- the emission of light into targeted tissue is most commonly done by one or more LEDs or laser diodes (as light source), and the collection of light is most commonly done directly using a photosensor (as light sensor, such as a photodiode) close to the targeted tissue.
- a photosensor as light sensor, such as a photodiode
- US 2013/0131519 A1 discloses a monitoring device for the ear where the light is delivered to the ear canal through a light guide and where the light is collected from the ear region and guided to the optical detector. This enables sensing a position on the body difficult to access such as the inner ear. However, it suffers from low efficacy in light coupling into the light guide, loss within the guide and low light capture.
- US 2015/094550 A1 , EP 3020331 A1 , and US 2007/129613 A1 disclose devices, in which a light source is equipped with a wavelength conversion means to alter the wavelength of the light emitted by the light source.
- EP 2401958 A1 discloses a dental intraoral observation equipment capable of obtaining a sharp and easily observable image even in a QLF method and includes a light source unit including a white light-emitting diode light source and a light-emitting diode light source for producing fluorescence having a peak within a wavelength range of 360 nm to 420 nm, an image taking device which receives a light emitted from the light source unit and converts the light into electrical signals, a first tuning means which shields against or damps a light having a wavelength component of 420 nm or less, a second tuning means which damps the amount of light having a wavelength component of 450 nm to 600 nm, and a signal treating means configured to treat the electrical signals converted by the image taking device, wherein, in a normal observation mode where only the white light-emitting diode light source is turned on, the signal treating means modifies the received light signals in accordance with predetermined relations, and in a QLF mode where only
- US 2014/058227 A1 discloses a measuring device comprising a transmissive suction mechanism, a suction hole, provided in the suction mechanism, through which skin is pulled into the suction mechanism, and an exhaust hole, provided in the suction mechanism, through which air in the suction mechanism is removed so as to reduce the pressure in the suction mechanism.
- US 2013/215496 A1 discloses a device and related fabrication method provided for an organic/inorganic hybrid optical amplifier with a function of converting infrared light to visible light.
- a device in accordance with the invention is defined in claim 1.
- the present invention is based on the idea to improve the capture of the light scattered back from the tissue through a larger surface and detection by a (small) sensor.
- a wavelength converter is used in the optical path between the tissue and the light sensor to convert the wavelength of the light scattered back from the tissue to a different wavelength. The converted light is then guided within the wavelength converter to the light sensor.
- a wavelength converter is introduced, sometimes also referred to as luminescent concentrator or light concentrator.
- a wavelength converter is typically made of a glass doped with a fluorescent dye.
- the fluorescent dye converts the light into a longer wavelength emitted in all directions. A large part of the light is trapped in the material due to total internal reflection.
- Wavelength converters per se are generally known and e.g. described in US 7,982,229 B2 . In embodiments of the presented device such a known wavelength converter may be used.
- the light that is captured by the photodetector in a conventional sensing device comes from only a small part in the skin and depends very much on the local structure in the skin. Therefore it is prone to motion artefacts caused by shifting of the sensor over the skin. With the presented device a larger part of the skin is probed so that the motion artefacts are reduced.
- the presented device does not simply use a larger sensor or multiple sensors to capture more light, which would add further limitations due to size, shape, cost and more complex electronics, but mere an additional wavelength converter is integrated into the device.
- said wavelength converter comprises a doped material arranged for converting the wavelength of the received light.
- a material doped with fluorescent dye or quantum dots may be used which can be easily implemented at low costs for the desired purpose.
- the material may e.g. be a light transmissive material such as crystalline, glass, ceramic or polymeric material.
- the shape and material are preferably designed to guide the converted light within the wavelength converter.
- the wavelength converter has a width selected to absorb more than 95% of the light source light, e.g. the wavelength converter may have a width selected from the range of 0.05-3 cm, especially 0.1-1.5 cm, such as 0.2-0.5 cm. With the preferably used fluorescent dye concentration, such width is enough to absorb substantially all light received from the tissue.
- the wavelength converter is preferably configured to convert the received light into a second wavelength that is longer than the first wavelength. Longer wavelengths generally have a lower refractive index, so they may be less efficiently trapped in the wavelength converter. Further, the sensor should have good sensitivity for the detected wavelength and preferably low sensitivity for the emitted wavelength, which can also be supported with this embodiment.
- the wavelength converter may further comprise one or more radiation input faces. These one or more faces are configured to receive light scattered from the tissue. The scattered light may provide light to a single face, or to a plurality of faces of the wavelength converter.
- said wavelength converter is arranged between the light source and the light sensor for receiving light scattered back or reflected from the tissue.
- it may be formed as a rod or cylinder and is arranged such that it receives light at a lateral side surface and emits converted light at a first front surface. In this way a compact design can be achieved.
- the wavelength converter comprises a mirror at a first front surface and/or at a second front surface opposite the first front surface for internally reflecting the light. This further improves the efficiency.
- a mirror may be arranged at the first front surface.
- the wavelength converter may also be made of a ceramic material, which generally has a large hardness and resistivity against chemicals.
- Practically usable materials for the wavelength converter include one or more of the following materials:
- the wavelength converter comprises an outcoupling element, in particular a tapered outcoupling element, a lens, a fluid, a polymer, a glue, a gel or a collimator.
- an outcoupling element in particular a tapered outcoupling element, a lens, a fluid, a polymer, a glue, a gel or a collimator.
- the outcoupling element may be arranged at the first front surface, but may also be arranged on any other surface for practical reasons.
- the wavelength converter may be formed as a disk or ring, wherein the light source is arranged in a central area of the wavelength converter the light sensor is arranged at an edge of the wavelength converter.
- the light source preferably comprises one or more LEDs, arrays of LEDs, or lasers.
- the light source comprises two light source elements for emitting light at two different first wavelengths, in particular at a wavelength of visible light (e.g. red light) and a wavelength of infrared light (e.g. near-infrared light).
- the wavelength converter may also comprise two or more fluorescent dyes to convert the respective wavelength emitted by the respective light source element.
- the device may further comprise an evaluation unit arranged for retrieving a physiological parameter of a user carrying said device from the light received by the light sensor.
- physiological information such as heart rate, respiration rate, pulse arrival, blood pressure, oxygen saturation, may be obtained.
- a dichroic mirror may be placed between the wavelength converter and the tissue in order to allow the light scattered from the tissue to reach the wavelength converter and prevent the converted light of being reemitted to the tissue.
- Fig. 1 shows a side view of a first embodiment of a device 1 according to the present invention.
- the device 1 comprises a light source 10 for emitting light 2 of at least a first wavelength into tissue 3 of the subject, a wavelength converter 20 for receiving at least part of the emitted light 4 after interaction of the emitted light 2 with the tissue 3 and for converting the received light 4 into at least a second wavelength different from the first wavelength, and a light sensor 30 for receiving light 5 converted by said wavelength converter 20.
- Fig. 2 shows a schematic diagram of an embodiment of a wavelength converter 20 as used in an embodiment of the device according to the present invention.
- the wavelength converter 20 of this embodiment is formed as a plate, rod or cylinder and is made of a material 21 which is doped with fluorescent dye converting the wavelength of the light 4 to light 50 with a different, preferably longer wavelength and propagating in all directions. It is arranged such that it receives light 4 at a lateral side surface 22 and emits converted light 5 at a first front surface 23, also called outcoupling surface 23.
- the light 50 is thus maintained within the material 21 due to total internal reflection and can escape preferably only from the outcoupling surface 23. In this way the light intensity of the light 5 escaping from the outcoupling surface 23 is concentrated.
- a mirror 24 is placed at the opposite front surface 25 so that as much light as possible is reflected to the outcoupling surface 23.
- the light source 10 is for example an LED, an array of LEDs, a laser, etc.
- the light 2, 4 passes through the sensed region 3, which can be skin or any other body tissue.
- Using a wavelength converter allows converting almost all the light passing through the wavelength converter (independently of the direction of the light rays) into a second wavelength which will emit light in all directions. These light rays are then trapped inside the wavelength converter due to total internal reflection (in an exemplary implementation approx. 60% will remain in the wavelength converter).
- the wavelength converter 20 is preferable made of a ceramic material.
- these materials have, in general, a very high hardness, are very stable, do not "wear” with respect to optical properties and show a large resistivity against chemicals, thus enabling cleaning in various ways (both chemically and mechanically).
- the compositions of these ceramics can be tuned in such a way, that the absorbing light matches the emitting spectrum of the light source 2 and the absorption spectrum of the targeted tissue 3.
- the concentration of luminescent sites (e.g. Ce) in the converter material 21 is high enough to have more than 99% conversion. That implies that the absorption length for the incident light 4 should be less than 0.22 times the plate thickness.
- an optional outcoupling element 26 may be provided at the first front surface 23 (shown with dashed lines in Fig. 2 ).
- the outcoupling element can e.g. have a tapered angle, e.g. in the range of 30° to 60°, e.g. of 45°.
- the outcoupling of light from the wavelength converter 20 to the light sensor 30 can be enhanced using a fluid (such as oil, gel), a lens, a collimator as outcoupling element 26.
- Fig. 3 shows a top view of a second embodiment of a device 2according to the present invention.
- the light source 10 is in the middle surrounded by the wavelength converter 20 that has the form of a disk.
- the light sensor 30 is arranged on a circumferential side surface (edge) of the disk-shaped wavelength converter 20.
- Fig. 4 shows a top view of a third embodiment of a device 3 according to the present invention.
- the wavelength converter 20 is formed in the shape of a ring to capture the light at a specific distance from the light source 10 in order to capture light having travelled deeper in the tissue.
- the light source may contain an LED array including LEDs of different colors.
- a device 4 used in a wristwatch 5 is illustrated in Fig. 5 .
- the device 4 is arranged at the lower surface 6 of the wristwatch so that it is in contact with the skin when worn by a user.
- the light source is formed by two LEDs of different colors, in particular a first LED 11 emitting red light and a second LED 12 emitting infrared light.
- the light sensor 30 is in the central area and waveguide converters 20 are arranged between the LEDs 11, 12 and the light sensor 30.
- the light sensor 30 (and/or a processor evaluating the sensed signals) can distinguish between light originating from the first LED 11 and light originating from the second LED 12 by using the time at which the light is sensed, as usually in PPG sensors with LEDs of different colors, which alternate in their on and off states (i.e. when one LED is emitting light, the other is not and vice versa).
- the device further comprises an evaluation unit 40, e.g. a processor, for evaluating the sensed signals and for retrieving a physiological parameter of a user carrying said device from the light received by the light sensor 30, i.e. the sensed signals.
- an evaluation unit 40 e.g. a processor
- the sensed signals are transmitted (in a wired or wireless manner) to an external evaluation unit, e.g. to a smartphone, computer, laptop, patient monitor, etc. for further processing.
- Fig. 6 shows a side view of a pulse oximeter 7 representing a fifth embodiment of a device according to the present invention.
- the pulse oximeter 7 is configured as finger clip for monitoring SpO2 of the subject.
- the two LEDs 11, 12 are arranged on a first side of the finger 100.
- the wavelength converter 20 and the photodiode 30 are arranged on the other side of the finger 100, i.e. light emitted by the LEDs 11, 12 is transmitted through the finger 100 and the received by the wavelength converter 20.
- the photodiode 30 is arranged on a lateral side of the wavelength converter 20 in this embodiment, from which the converted light is output.
- the present invention is not limited to devices of a reflective type making use of light reflected from tissue, but can also be applied in device of a transmissive type making use of light transmitted through tissue. Also hybrid forms of devices may be used. For instance, in the embodiment shown in Fig. 6 the wavelength converter may be arranged around part or the complete finger to collect light scattered by the tissue in all directions.
- the present invention can be used for unobtrusive monitoring of physiological parameters such as heart rate, respiration rate, blood oxygen saturation and (a surrogate for) blood pressure .
- Applications range from healthy living (think of activity trackers and sports watches), to home monitoring of elderly, patients with chronic diseases and for hospital to home, to hospital use, such as in the ICU and OR.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Human Computer Interaction (AREA)
- General Physics & Mathematics (AREA)
- Multimedia (AREA)
- Theoretical Computer Science (AREA)
- Physiology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Description
- The present invention relates to a device for detecting light allowing retrieval of a physiological parameter of a user carrying said device.
- Light based non-invasive monitoring devices of physiological parameter (or signal) rely on the light emission to a targeted body part, the light absorption/scattering proprieties of the tissue (including the blood) and the collection of the scattered or transmitted light. Every heart beat leads to a blood pulse in the body part, with an increased amount of blood and therefore an increased light absorption and thus a decreased collection of scattered/transmitted light by the light detector. The optical method to measure such blood volume changes is called photoplethysmography (PPG). Various vital signs can be derived from PPG, namely heart rate, respiration rate, blood oxygen saturation, and it might even be used as a surrogate measurement for blood pressure. When it is used to derive the blood oxygen saturation, the method is called pulse oximetry (SpO2). SpO2 sensors are widely used in hospital settings, whereas PPG heart rate measurements find applications in wearable devices as activity trackers or sports watches.
- The emission of light into targeted tissue (or skin; both being used herein as meaning the same) is most commonly done by one or more LEDs or laser diodes (as light source), and the collection of light is most commonly done directly using a photosensor (as light sensor, such as a photodiode) close to the targeted tissue. Part of the light from the light source that has entered the tissue / skin comes back out of the tissue / skin after scattering in the tissue / skin. In known sensors, only a small part of that light is captured by the light sensor, while the rest of the light is lost.
-
US 2013/0131519 A1 discloses a monitoring device for the ear where the light is delivered to the ear canal through a light guide and where the light is collected from the ear region and guided to the optical detector. This enables sensing a position on the body difficult to access such as the inner ear. However, it suffers from low efficacy in light coupling into the light guide, loss within the guide and low light capture. -
US 2015/094550 A1 ,EP 3020331 A1 , andUS 2007/129613 A1 disclose devices, in which a light source is equipped with a wavelength conversion means to alter the wavelength of the light emitted by the light source. -
EP 2401958 A1 discloses a dental intraoral observation equipment capable of obtaining a sharp and easily observable image even in a QLF method and includes a light source unit including a white light-emitting diode light source and a light-emitting diode light source for producing fluorescence having a peak within a wavelength range of 360 nm to 420 nm, an image taking device which receives a light emitted from the light source unit and converts the light into electrical signals, a first tuning means which shields against or damps a light having a wavelength component of 420 nm or less, a second tuning means which damps the amount of light having a wavelength component of 450 nm to 600 nm, and a signal treating means configured to treat the electrical signals converted by the image taking device, wherein, in a normal observation mode where only the white light-emitting diode light source is turned on, the signal treating means modifies the received light signals in accordance with predetermined relations, and in a QLF mode where only the light-emitting diode light source for producing fluorescence is turned on, the signal treating means modifies the received light signals in accordance with other predetermined relations. -
US 2014/058227 A1 discloses a measuring device comprising a transmissive suction mechanism, a suction hole, provided in the suction mechanism, through which skin is pulled into the suction mechanism, and an exhaust hole, provided in the suction mechanism, through which air in the suction mechanism is removed so as to reduce the pressure in the suction mechanism. -
US 2013/215496 A1 discloses a device and related fabrication method provided for an organic/inorganic hybrid optical amplifier with a function of converting infrared light to visible light. - It is an object of the present invention to provide a device for detecting light allowing retrieval of a physiological parameter of a user carrying said device with an increased light sensing efficiency and efficacy.
- A device in accordance with the invention is defined in
claim 1. - The present invention is based on the idea to improve the capture of the light scattered back from the tissue through a larger surface and detection by a (small) sensor. In particular, a wavelength converter is used in the optical path between the tissue and the light sensor to convert the wavelength of the light scattered back from the tissue to a different wavelength. The converted light is then guided within the wavelength converter to the light sensor.
- In this invention, a wavelength converter is introduced, sometimes also referred to as luminescent concentrator or light concentrator. A wavelength converter is typically made of a glass doped with a fluorescent dye. The fluorescent dye converts the light into a longer wavelength emitted in all directions. A large part of the light is trapped in the material due to total internal reflection. Wavelength converters per se are generally known and e.g. described in
US 7,982,229 B2 . In embodiments of the presented device such a known wavelength converter may be used. - Whereas in conventional PPG only about 1 % of the light emitted from the light source to the skin is captured by the sensor although around 50% of the light emitted is scattered back from the skin, leading to a low and noisy signal, according to the present invention much more light can be captured (e.g. more than 20% or even more than 50%).
- Further, with a conventional sensing device a high amount of power from the light source is required to obtain a good signal, thus limiting the battery life of a wearable device. Battery life is very important in nowadays wearables that should be worn continuously. Due to the improved efficiency of the presented device, battery life can be extended.
- The light that is captured by the photodetector in a conventional sensing device comes from only a small part in the skin and depends very much on the local structure in the skin. Therefore it is prone to motion artefacts caused by shifting of the sensor over the skin. With the presented device a larger part of the skin is probed so that the motion artefacts are reduced.
- The presented device does not simply use a larger sensor or multiple sensors to capture more light, which would add further limitations due to size, shape, cost and more complex electronics, but mere an additional wavelength converter is integrated into the device.
- According to an embodiment said wavelength converter comprises a doped material arranged for converting the wavelength of the received light. For instance, a material doped with fluorescent dye or quantum dots may be used which can be easily implemented at low costs for the desired purpose. The material may e.g. be a light transmissive material such as crystalline, glass, ceramic or polymeric material.
- The shape and material are preferably designed to guide the converted light within the wavelength converter. Preferably, a material with refractive index between 1.42 and 1.8, more preferably between 1.48 and 1.54, is used.
- In an embodiment, the wavelength converter has a width selected to absorb more than 95% of the light source light, e.g. the wavelength converter may have a width selected from the range of 0.05-3 cm, especially 0.1-1.5 cm, such as 0.2-0.5 cm. With the preferably used fluorescent dye concentration, such width is enough to absorb substantially all light received from the tissue.
- The wavelength converter is preferably configured to convert the received light into a second wavelength that is longer than the first wavelength. Longer wavelengths generally have a lower refractive index, so they may be less efficiently trapped in the wavelength converter. Further, the sensor should have good sensitivity for the detected wavelength and preferably low sensitivity for the emitted wavelength, which can also be supported with this embodiment.
- The wavelength converter may further comprise one or more radiation input faces. These one or more faces are configured to receive light scattered from the tissue. The scattered light may provide light to a single face, or to a plurality of faces of the wavelength converter.
- According to the invention said wavelength converter is arranged between the light source and the light sensor for receiving light scattered back or reflected from the tissue.
- According to the invention it may be formed as a rod or cylinder and is arranged such that it receives light at a lateral side surface and emits converted light at a first front surface. In this way a compact design can be achieved.
- Preferably, the wavelength converter comprises a mirror at a first front surface and/or at a second front surface opposite the first front surface for internally reflecting the light. This further improves the efficiency. In case the first front surface is not totally covered by the light sensor, a mirror may be arranged at the first front surface.
- The wavelength converter may also be made of a ceramic material, which generally has a large hardness and resistivity against chemicals.
- Practically usable materials for the wavelength converter include one or more of the following materials:
- glass-ceramics doped with Mn2+, in particular one or more of garnets or cubic crystals doped/co-doped with Mn2+, Mn4+, Ce3+, Pr3+, Eu3+, Sm3+, Eu2+, Yb2+; non-cubic crystals, in particular phosphors doped with Ce3+, Pr3+, Eu2+, Yb2+; Eu3+ incorporated into index-matching matrixes, in particular TeO2, SnO/P2O5, or Bi2O3 containing glasses, high-index polyimide;
- glass-ceramics doped with Co3+, in particular one or more of garnets or cubic crystals doped/co-doped with Ce3+, Mn2+, Mn4+, Cr3+ ; non-cubic crystals, in particular phosphors doped with Ce3+, Pr3+, Eu2+, Yb2+, Eu3+, Tm3+, Sm2+, Cr3+, Ti3+ incorporated into index-matching matrixes;
- garnets or cubic crystals doped/co-doped with Cr3+, Nd3+, Tm3+.
- In one embodiment the wavelength converter comprises an outcoupling element, in particular a tapered outcoupling element, a lens, a fluid, a polymer, a glue, a gel or a collimator. This increases the transmission from the wavelength converter to the sensor and thus leads to a large signal output. The outcoupling element may be arranged at the first front surface, but may also be arranged on any other surface for practical reasons.
- Also according to the invention the wavelength converter may be formed as a disk or ring, wherein the light source is arranged in a central area of the wavelength converter the light sensor is arranged at an edge of the wavelength converter.
- The light source preferably comprises one or more LEDs, arrays of LEDs, or lasers. For instance, in a practical embodiment for SpO2 measurements, the light source comprises two light source elements for emitting light at two different first wavelengths, in particular at a wavelength of visible light (e.g. red light) and a wavelength of infrared light (e.g. near-infrared light). In this case, the wavelength converter may also comprise two or more fluorescent dyes to convert the respective wavelength emitted by the respective light source element.
- The device may further comprise an evaluation unit arranged for retrieving a physiological parameter of a user carrying said device from the light received by the light sensor. Thus, physiological information such as heart rate, respiration rate, pulse arrival, blood pressure, oxygen saturation, may be obtained.
- Additionally, a dichroic mirror may be placed between the wavelength converter and the tissue in order to allow the light scattered from the tissue to reach the wavelength converter and prevent the converted light of being reemitted to the tissue.
- These and other aspects of the invention will be apparent from and elucidated with reference to the embodiment(s) described hereinafter. In the following drawings
-
Fig. 1 shows a side view of a first embodiment of a device according to the present invention, -
Fig. 2 shows a schematic diagram of an embodiment of a wavelength converter as used in an embodiment of the device according to the present invention, -
Fig. 3 shows a top view of a second embodiment of a device according to the present invention, -
Fig. 4 shows a top view of a third embodiment of a device according to the present invention, -
Fig. 5 shows a perspective view of a wrist watch including a fourth embodiment of a device according to the present invention, and -
Fig. 6 shows a side view of a pulse oximeter representing a fifth embodiment of a device according to the present invention. -
Fig. 1 shows a side view of a first embodiment of adevice 1 according to the present invention. Thedevice 1 comprises alight source 10 for emittinglight 2 of at least a first wavelength intotissue 3 of the subject, awavelength converter 20 for receiving at least part of the emittedlight 4 after interaction of the emitted light 2 with thetissue 3 and for converting the received light 4 into at least a second wavelength different from the first wavelength, and alight sensor 30 for receiving light 5 converted by saidwavelength converter 20.Fig. 2 shows a schematic diagram of an embodiment of awavelength converter 20 as used in an embodiment of the device according to the present invention. Thewavelength converter 20 of this embodiment is formed as a plate, rod or cylinder and is made of a material 21 which is doped with fluorescent dye converting the wavelength of the light 4 to light 50 with a different, preferably longer wavelength and propagating in all directions. It is arranged such that it receives light 4 at alateral side surface 22 and emits converted light 5 at a firstfront surface 23, also calledoutcoupling surface 23. The light 50 is thus maintained within thematerial 21 due to total internal reflection and can escape preferably only from theoutcoupling surface 23. In this way the light intensity of thelight 5 escaping from theoutcoupling surface 23 is concentrated. Optionally, amirror 24 is placed at the oppositefront surface 25 so that as much light as possible is reflected to theoutcoupling surface 23. - The
light source 10 is for example an LED, an array of LEDs, a laser, etc. The 2, 4 passes through the sensedlight region 3, which can be skin or any other body tissue. - Using a wavelength converter allows converting almost all the light passing through the wavelength converter (independently of the direction of the light rays) into a second wavelength which will emit light in all directions. These light rays are then trapped inside the wavelength converter due to total internal reflection (in an exemplary implementation approx. 60% will remain in the wavelength converter).
- In an embodiment the
wavelength converter 20 is preferable made of a ceramic material. Advantages of this are that these materials have, in general, a very high hardness, are very stable, do not "wear" with respect to optical properties and show a large resistivity against chemicals, thus enabling cleaning in various ways (both chemically and mechanically). Furthermore, the compositions of these ceramics can be tuned in such a way, that the absorbing light matches the emitting spectrum of thelight source 2 and the absorption spectrum of the targetedtissue 3. - Several exemplary potential materials are identified with various absorption/emission wavelengths that can provide the desired properties:
- glass-ceramics doped with Mn2+; garnets and other cubic crystals (Spinel, perovskite, pyrochlore, etc.) doped/co-doped with Mn2+, Mn4+, Ce3+, Pr3+, Eu3+, Sm3+, Eu2+, Yb2+; non-cubic crystals, such as phosphors doped with Ce3+, Pr3+, Eu2+, Yb2+; Eu3+ incorporated into index-matching matrixes (e.g. TeO2, SnO/P2O5, or Bi2O3 containing glasses, high-index polyimide);
- glass-ceramics doped with Co3+; garnets and other cubic crystals doped/co-doped with Ce3+, Mn2+, Mn4+, Cr3+ ; non-cubic crystals, such as phosphors doped with Ce3+, Pr3+, Eu2+, Yb2+, Eu3+, Tm3+, Sm2+, Cr3+, Ti3+ incorporated into index-matching matrixes;
- garnets and other cubic crystals doped/co-doped with Cr3+, Nd3+, Tm3+.
- Preferably, the concentration of luminescent sites (e.g. Ce) in the
converter material 21 is high enough to have more than 99% conversion. That implies that the absorption length for theincident light 4 should be less than 0.22 times the plate thickness. - In other embodiments, an
optional outcoupling element 26 may be provided at the first front surface 23 (shown with dashed lines inFig. 2 ). The outcoupling element can e.g. have a tapered angle, e.g. in the range of 30° to 60°, e.g. of 45°. In another embodiment, the outcoupling of light from thewavelength converter 20 to thelight sensor 30 can be enhanced using a fluid (such as oil, gel), a lens, a collimator asoutcoupling element 26. -
Fig. 3 shows a top view of a second embodiment of a device 2according to the present invention. In this embodiment thelight source 10 is in the middle surrounded by thewavelength converter 20 that has the form of a disk. Thelight sensor 30 is arranged on a circumferential side surface (edge) of the disk-shapedwavelength converter 20. -
Fig. 4 shows a top view of a third embodiment of adevice 3 according to the present invention. In this embodiment thewavelength converter 20 is formed in the shape of a ring to capture the light at a specific distance from thelight source 10 in order to capture light having travelled deeper in the tissue. - The light source may contain an LED array including LEDs of different colors. Such an embodiment of a
device 4 used in awristwatch 5 is illustrated inFig. 5 . Thedevice 4 is arranged at thelower surface 6 of the wristwatch so that it is in contact with the skin when worn by a user. - In this embodiment the light source is formed by two LEDs of different colors, in particular a
first LED 11 emitting red light and asecond LED 12 emitting infrared light. Thelight sensor 30 is in the central area andwaveguide converters 20 are arranged between the 11, 12 and theLEDs light sensor 30. - It is known that adding one or more extra colors (with a different absorption coefficient in blood and/or a different penetration depth) can be used to reduce motion artefacts. Further, the use of at least two colors (having different absorption and/or scattering coefficients for oxygenated versus deoxygenated blood) is required for deriving the oxygen saturation in the blood. Although the wavelength converter changes the wavelength of the colors, this has no further implications, because the wavelength is changed only after it has been scattered by the skin (including the blood) and therefore, the information of interest has already been obtained before the wavelength is changed.
- The light sensor 30 (and/or a processor evaluating the sensed signals) can distinguish between light originating from the
first LED 11 and light originating from thesecond LED 12 by using the time at which the light is sensed, as usually in PPG sensors with LEDs of different colors, which alternate in their on and off states (i.e. when one LED is emitting light, the other is not and vice versa). - In another embodiment the device further comprises an
evaluation unit 40, e.g. a processor, for evaluating the sensed signals and for retrieving a physiological parameter of a user carrying said device from the light received by thelight sensor 30, i.e. the sensed signals. Such anoptional evaluation unit 40 is also shown inFig. 5 with dashed lines. In an alternative embodiment the sensed signals are transmitted (in a wired or wireless manner) to an external evaluation unit, e.g. to a smartphone, computer, laptop, patient monitor, etc. for further processing. -
Fig. 6 shows a side view of apulse oximeter 7 representing a fifth embodiment of a device according to the present invention. Thepulse oximeter 7 is configured as finger clip for monitoring SpO2 of the subject. The two 11, 12 are arranged on a first side of theLEDs finger 100. Thewavelength converter 20 and thephotodiode 30 are arranged on the other side of thefinger 100, i.e. light emitted by the 11, 12 is transmitted through theLEDs finger 100 and the received by thewavelength converter 20. Thephotodiode 30 is arranged on a lateral side of thewavelength converter 20 in this embodiment, from which the converted light is output. - Hence, the present invention is not limited to devices of a reflective type making use of light reflected from tissue, but can also be applied in device of a transmissive type making use of light transmitted through tissue. Also hybrid forms of devices may be used. For instance, in the embodiment shown in
Fig. 6 the wavelength converter may be arranged around part or the complete finger to collect light scattered by the tissue in all directions. - Other embodiments may be envisaged for specific location of the body such as the nose and the ear where access is more difficult.
- The present invention can be used for unobtrusive monitoring of physiological parameters such as heart rate, respiration rate, blood oxygen saturation and (a surrogate for) blood pressure . Applications range from healthy living (think of activity trackers and sports watches), to home monitoring of elderly, patients with chronic diseases and for hospital to home, to hospital use, such as in the ICU and OR.
- While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description are to be considered illustrative or exemplary and not restrictive; the invention is not limited to the disclosed embodiments. Other variations to the disclosed embodiments can be understood and effected by those skilled in the art in practicing the claimed invention, from a study of the drawings, the disclosure, and the appended claims.
- In the claims, the word "comprising" does not exclude other elements or steps, and the indefinite article "a" or "an" does not exclude a plurality. A single element or other unit may fulfill the functions of several items recited in the claims. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage.
- Any reference signs in the claims should not be construed as limiting the scope.
Claims (10)
- Device for detecting light allowing retrieval of a physiological parameter of a user carrying said device, said device (1, 2, 3, 4) comprising:- a light source (10) arranged for emitting light of at least a first wavelength into tissue of the subject,- a wavelength converter (20) arranged for receiving at least part of the emitted light after interaction of the emitted light with the tissue and for converting the received light into at least a second wavelength different from the first wavelength, and- a light sensor (30) arranged for receiving light converted by said wavelength converter,said wavelength converter (20) is arranged between the light source (10) and the light sensor (30) for receiving light reflected or scattered back from the tissue in response to the light emitted by the light source into the tissue, and characterized in thatsaid wavelength converter (20) is formedwherein the light source (10) is arranged in a central area (27) of the wavelength converter (20) and the light sensor (30) is arranged at an edge (28) of the wavelength converter (20) facing the curved surface.i) as a rod or cylinder and is arranged such that it receives light at a lateral side surface (22) and emits converted light at a first front surface (23) orii) as a disk or ring, said disk or ring having a curved surface,
- Device as claimed in claim 1,
wherein said wavelength converter (20) comprises a doped material (21) arranged for converting the wavelength of the received light, in particular a material (21) doped with fluorescent dye or quantum dots. - Device as claimed in claim 1,
wherein said wavelength converter (20) is configured to convert the received light into a second wavelength that is longer than the first wavelength. - Device as claimed in claim 1,
wherein said wavelength converter (20) comprises a mirror (24) at a first front surface (23) and/or at a second front surface (25) opposite the first front surface for internally reflecting the light. - Device as claimed in claim 1,
wherein said wavelength converter (20) is made of a ceramic material. - Device as claimed in claim 1,
wherein said wavelength converter (20) is made of one of the following materials:- glass-ceramics doped with Mn2+, in particular one or more of garnets or cubic crystals doped/co-doped with Mn2+, Mn4+, Ce3+, Pr3+, Eu3+, Sm3+, Eu2+, Yb2+; non-cubic crystals, in particular phosphors doped with Ce3+, Pr3+, Eu2+, Yb2+; Eu3+ incorporated into index-matching matrixes, in particular TeO2, SnO/P2O5, or Bi2O3 containing glasses, high-index polyimide;- glass-ceramics doped with Co3+, in particular one or more of garnets or cubic crystals doped/co-doped with Ce3+, Mn2+, Mn4+, Cr3+ ; non-cubic crystals, in particular phosphors doped with Ce3+, Pr3+, Eu2+, Yb2+, Eu3+, Tm3+, Sm2+, Cr3+, Ti3+ incorporated into index-matching matrixes;- garnets or cubic crystals doped/co-doped with Cr3+, Nd3+, Tm3+. - Device as claimed in claim 1,
wherein said wavelength converter (20) comprises an outcoupling element (26), in particular a tapered outcoupling element, a lens, a fluid, a polymer, a glue, a gel or a collimator. - Device as claimed in claim 1,
wherein said light source (10) comprises one or more LEDs, arrays of LEDs, or lasers. - Device as claimed in claim 1,
wherein said light source (10) comprises two light source elements (11, 12) for emitting light at two different first wavelengths, in particular at a wavelength of visible light and a wavelength of infrared light. - Device as claimed in claim 1,
further comprising an evaluation unit (40) arranged for retrieving a physiological parameter of a user carrying said device from the light received by the light sensor (30).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16197460 | 2016-11-07 | ||
| PCT/EP2017/078508 WO2018083351A1 (en) | 2016-11-07 | 2017-11-07 | Device and method for physiological parameter detection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3534775A1 EP3534775A1 (en) | 2019-09-11 |
| EP3534775B1 true EP3534775B1 (en) | 2023-06-07 |
Family
ID=57240990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17800470.1A Active EP3534775B1 (en) | 2016-11-07 | 2017-11-07 | Device for physiological parameter detection |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11482034B2 (en) |
| EP (1) | EP3534775B1 (en) |
| JP (1) | JP7245774B2 (en) |
| CN (1) | CN109952057A (en) |
| WO (1) | WO2018083351A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102018221854A1 (en) * | 2018-12-17 | 2020-06-18 | Osram Opto Semiconductors Gmbh | Pulse sensor for detecting the pulse of a living being |
| US12350027B2 (en) | 2020-05-22 | 2025-07-08 | Google Llc | Erbium doped glass for optical amplification in detecting a photoplethysmography |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012160893A1 (en) * | 2011-05-26 | 2012-11-29 | シャープ株式会社 | Skin sampling member, measuring device, and measuring method |
| US20130215496A1 (en) * | 2010-08-18 | 2013-08-22 | Dayan Ban | Organic/inorganic hybrid optical amplifier with wavelength conversion |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6466806B1 (en) * | 2000-05-17 | 2002-10-15 | Card Guard Scientific Survival Ltd. | Photoacoustic material analysis |
| GB2408209A (en) | 2003-11-18 | 2005-05-25 | Qinetiq Ltd | Flexible medical light source |
| CN100472827C (en) | 2004-11-18 | 2009-03-25 | 皇家飞利浦电子股份有限公司 | Light emitting device with switching structure |
| KR100827138B1 (en) | 2006-08-10 | 2008-05-02 | 삼성전자주식회사 | Biometric information measuring device |
| WO2008085411A2 (en) * | 2006-12-27 | 2008-07-17 | Valencell, Inc. | Multi-wavelength optical devices and methods of using same |
| CN101939402A (en) * | 2008-02-11 | 2011-01-05 | 皇家飞利浦电子股份有限公司 | LED based light source for improved color saturation |
| US8788002B2 (en) | 2009-02-25 | 2014-07-22 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
| JP5410374B2 (en) * | 2010-07-02 | 2014-02-05 | インスペクター リサーチ システムズ ベーフェー | Intraoral observation device |
| JP5658993B2 (en) * | 2010-12-15 | 2015-01-28 | 株式会社日立製作所 | Biological measuring device |
| JP6382792B2 (en) * | 2012-03-30 | 2018-08-29 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Optical cavity including light emitting device and wavelength converting material |
| CN103630506B (en) | 2012-08-20 | 2016-10-26 | 台医光电科技股份有限公司 | Detection module and detection device |
| US20140107495A1 (en) | 2012-10-17 | 2014-04-17 | Nokia Corporation | Wearable Apparatus and Associated Methods |
| EP2769667A1 (en) * | 2013-02-22 | 2014-08-27 | Koninklijke Philips N.V. | Marker with light emitting area for use in determining vital sign information |
| CN105074944A (en) * | 2013-03-29 | 2015-11-18 | 皇家飞利浦有限公司 | Light emitting device comprising wavelength converter |
| EP3001803A1 (en) * | 2013-05-03 | 2016-04-06 | Koninklijke Philips N.V. | Light source with adapted spectal output |
| US20150094550A1 (en) * | 2013-09-30 | 2015-04-02 | General Electric Company | Dual-spectra pulse oximeter sensors and methods of making the same |
| KR102270798B1 (en) * | 2013-12-16 | 2021-06-30 | 삼성메디슨 주식회사 | Photoacoustic probe and photoacoustic diagnostic apparatus |
| CN106659402A (en) | 2014-06-27 | 2017-05-10 | 皇家飞利浦有限公司 | Animal vital sign detection system |
| EP3206567A1 (en) * | 2014-10-13 | 2017-08-23 | Glusense, Ltd. | Analyte-sensing device |
| EP3015848A1 (en) | 2014-10-30 | 2016-05-04 | Nokia Technologies OY | Apparatus and method for detecting light reflected from an object |
| EP3015062A1 (en) | 2014-10-30 | 2016-05-04 | ams AG | Optical sensor arrangement for an optical measurement of biological parameters and watch comprising the optical sensor arrangement |
| US20160139631A1 (en) | 2014-11-14 | 2016-05-19 | Polar Electro Oy | Wrist device efficiency |
| JP2016174766A (en) * | 2015-03-20 | 2016-10-06 | 国立大学法人名古屋大学 | Non-contact biological information sensor |
-
2017
- 2017-11-07 WO PCT/EP2017/078508 patent/WO2018083351A1/en not_active Ceased
- 2017-11-07 EP EP17800470.1A patent/EP3534775B1/en active Active
- 2017-11-07 CN CN201780068672.8A patent/CN109952057A/en active Pending
- 2017-11-07 US US16/346,891 patent/US11482034B2/en active Active
- 2017-11-07 JP JP2019521085A patent/JP7245774B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130215496A1 (en) * | 2010-08-18 | 2013-08-22 | Dayan Ban | Organic/inorganic hybrid optical amplifier with wavelength conversion |
| WO2012160893A1 (en) * | 2011-05-26 | 2012-11-29 | シャープ株式会社 | Skin sampling member, measuring device, and measuring method |
| US20140058227A1 (en) * | 2011-05-26 | 2014-02-27 | Sharp Kabushiki Kaisha | Measuring device, and measuring method |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018083351A1 (en) | 2018-05-11 |
| CN109952057A (en) | 2019-06-28 |
| JP2019533509A (en) | 2019-11-21 |
| US11482034B2 (en) | 2022-10-25 |
| EP3534775A1 (en) | 2019-09-11 |
| US20200193121A1 (en) | 2020-06-18 |
| JP7245774B2 (en) | 2023-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12076142B2 (en) | Physiological monitoring system for measuring oxygen saturation | |
| CN113597280B (en) | PPG sensor with high signal-to-noise ratio | |
| RU2720663C2 (en) | Optical sensor of vital signs | |
| WO2005010567A2 (en) | Low profile fiber optic vital signs sensor | |
| EP3534775B1 (en) | Device for physiological parameter detection | |
| WO2006079862A2 (en) | Pulse oximeter and casing for anchoring a sensor | |
| KR102223689B1 (en) | Apparatus for measuring bio-information | |
| RU162684U1 (en) | HUMAN PULSE WAVE FORM OPTICAL SENSOR | |
| RU2839510C1 (en) | Optical sensor of short-wave infrared spectrum for biomedical applications | |
| JP2019097771A (en) | Pulse oximeter and probe for biological information measurement | |
| CN120694625A (en) | A wearable device worn on the head | |
| HK40064303B (en) | Physiological monitoring system for measuring oxygen saturation | |
| HK40064303A (en) | Physiological monitoring system for measuring oxygen saturation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20190607 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: KONINKLIJKE PHILIPS N.V. |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20220413 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20230105 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BOURQUIN, YANNYK PARULIAN JULIAN |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 1572303 Country of ref document: AT Kind code of ref document: T Effective date: 20230615 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017069764 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20230607 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230907 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1572303 Country of ref document: AT Kind code of ref document: T Effective date: 20230607 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230908 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231007 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231009 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231007 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602017069764 Country of ref document: DE |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
| 26N | No opposition filed |
Effective date: 20240308 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231107 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231107 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130 |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20231130 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231107 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231107 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R084 Ref document number: 602017069764 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: 746 Effective date: 20241217 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20241128 Year of fee payment: 8 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20241126 Year of fee payment: 8 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20241126 Year of fee payment: 8 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20171107 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20171107 |